Clinical trial

Ciprofol's Impact on Oxygenator Function in Extracorporeal Membrane Oxygenation (ECMO) Patients

NCT06934811

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-05-01

PhasePHASE4

Study timeline

Study start (estimated)2025-05-01Date precision: day

Registry last updated2025-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

ECMO Treatmentunresolved

ARDS (Acute Respiratory Distress Syndrome)unresolved

ECMO and Acute MIunresolved

Respiratory Failure Patients Treated With ECMOunresolved

Shock, Cardiogenicunresolved

Interventions

MidazolamDRUG · verified · RxNorm: midazolam

Sponsors & collaborators

First Affiliated Hospital of Wannan Medical Collegelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06934811 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.